Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2021 Dec 15;12:812384. doi: 10.3389/fphar.2021.812384

Corrigendum: C1q/TNF-Related Protein 9 Attenuates Atherosclerosis by Inhibiting Hyperglycemia-Induced Endothelial Cell Senescence Through the AMPKα/KLF4 Signaling Pathway

Gang Wang 1,2, Baihe Han 1,2, Ruoxi Zhang 3, Qi Liu 1,2, Xuedong Wang 1,2, Xingtao Huang 1,2, Dandan Liu 1,2, Weishen Qiao 1,2, Mengyue Yang 1,2, Xing Luo 1,2, Jingbo Hou 1,2,*, Bo Yu 1,2
PMCID: PMC8714943  PMID: 34975508

In the original article, there was a mistake in the artwork for Figure 2C as published. We made a careless mistake about p21 protein. The correct artwork appears below.

FIGURE 2.

FIGURE 2

Hyperglycemia-induced HUVEC senescence is KLF4 dependent. (A) KLF4, as measured by immunoblotting and qRT-PCR in HUVECs after transfection with siNC or siKLF4 for 48 h. (B) Cells were fixed and stained for SA-β-gal activity and the histogram represents the percentage of SA-β-gal-positive cells per microscopic field. Values represent mean ± SEM. *p < 0.05, **p < 0.01. (C) KLF4, p21, and TERT protein levels were determined by immunoblotting. (D–F) Results were normalized to controls, and histograms represent the relative intensity of KLF4, p21, and TERT. Values represent mean ± SEM (n = 3–4 per group). *p < 0.05, **p < 0.01, ***p < 0.001.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES